HappeningToo topic
Carfilzomib reports
Browse community reports connected to Carfilzomib. These reports can show that other people are describing similar experiences, but they do not prove that Carfilzomib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
23 problems
Back Pain while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and back pain appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and chills appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and constipation appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and cough appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and decreased appetite appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and dehydration appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and diarrhea appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and dizziness appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and fatigue appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and feeling abnormal appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and headache appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and hypotension appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and insomnia appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and malaise appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and muscle spasms appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and nausea appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and pain appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and peripheral swelling appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and rash appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and shortness of breath appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and vomiting appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and weakness appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Carfilzomib
FDA FAERS contains adverse-event reports in which Carfilzomib and weight decreased appear together. This does not establish that Carfilzomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →